This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The COVID-19 pandemic led to an unparalleled paradigm shift in the use of and the incorporation of new technologies into our workflows. This was particularly apparent in academia and the pharmaceutical industry, where we have seen words such as Teams and Zoom becoming part of our new lexicon of language for meetings. Now we reach for these types of online meetings without a second thought, due to the clear productivity benefits they provide over real in-person meetings. 1 However, notwithstandin
The COVID-19 pandemic had many pharmas turning to DCTs as a way to keep the clinical wheel turning. Can the industry keep that flexibility going forward?
130
130
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The COVID-19 pandemic had many pharmas turning to DCTs as a way to keep the clinical wheel turning. Can the industry keep that flexibility going forward?
When we think of notable civil rights issues in medicine, the best-known cases might be Henrietta Lacks , whose cells were taken without consent for research, or the participants of the Tuskegee Syphilis Study who were subject to unethical experiments. These are important events that changed the course of medicine, but they’re also examples in which Black people were unknowingly harmed as patients.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Beets may not be the first vegetable on your favorite foods list—many people have less-than-pleasant childhood memories of being forced to eat the canned version at dinner and would rather not revisit those memories as adults. But beets are really really good for your overall health and wellness. The part of the beet you typically eat, i.e., the bulbous part under the stem, is technically the “taproot” or “beetroot,” though most of us just call it a beet.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
To become more equitable and inclusive organizations, higher education and scientific institutions must go beyond increasing the number of people from underrepresented racial and ethnic groups in their ranks and change their cultures, a leading academic group said in a sweeping new report Tuesday. The report , from the National Academies of Sciences, Engineering, and Medicine, calls for such institutions to actively pursue antiracist initiatives to start overcoming the barriers and structural ra
Greg Bowman, a University of Pennsylvania biophysicist, had the kind of idea biotech venture capitalists salivate over. His lab had been working on how to drug “cryptic sites” on proteins that were previously thought unreachable by drug molecules. Machine learning, he believed, would make new types of medicine possible. The idea seemed ready to be spun out of his lab and into a company.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Biosimilars in Pharmaceuticals: Neuro-degenerative re
WASHINGTON — A popular Chinese vape company says it is donating thousands of dollars to the American Cancer Society in an effort to stop youth vaping, but the cancer organization says it never agreed to the partnership, and it’s ordering the company to stop. The company, Elf Bar, announced in January it was creating a program, dubbed the “Lighthouse Guardian Program,” to prevent youth vaping.
Over the last 20 years, the United States has made great strides in expanding access to health care, with 92% of Americans now covered by health insurance — a historic high. Yet millions of people still struggle to pay for their health care, from paying for medications to grappling with exorbitant hospital bills. These challenges can be mentally and emotionally taxing when access to quality care should bring peace of mind.
HRG reviewed 21 products in the health category, 86 in the wellness sector and 117 items in the beauty aisle to see which ones stood out as Products to Watch.
Rise and shine, everyone, another busy day is on the way. We can tell by the volume of traffic passing by the Pharmalot campus and the escalating pace at which the official mascot is barking at assorted neighbors and creatures. There is only one thing to do when this happens — fire up the coffee kettle to make some cups of stimulation. Our choice today is Vermont maple walnut, and we invite you to join us.
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Johnson & Johnson ( J&J ) has announced that Dr John Reed, PhD, will become the company’s Executive Vice President of Pharmaceuticals, R&D on April 3, 2023. Dr Reed commented on his forthcoming appointment: “I am deeply honoured and extremely excited to join Johnson & Johnson. I look forward to applying my passion for science, experience in drug discovery and development and commitment to helping patients in leading the talented Pharmaceutical R&D team.
WASHINGTON — Medicare advisers on Tuesday recommended that the program alter its requirements for drugs, diagnostics, and medical devices that face coverage restrictions to make the process more transparent and better incorporate diversity data. The niche regulatory tool, called a Coverage with Evidence Development, has gotten outsized attention recently because it has been applied to a new class of Alzheimer’s drugs that target amyloid plaques in the brain.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content